Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Pediatrics/Neonatology | Cardiology/Vascular Diseases | Family Medicine
 Disease Category: High Blood Pressure (Hypertension - Pediatric)
Location: United States, MO

Trial Information

An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertension

This study is for male and female patients that have moderate to severe high blood pressure(hypertension). The study compares 4 different combinations of 3 drugs to see which combinations are safe and can best help people with hypertension.

Patient Inclusion Criteria

  • Patients must be between 18 and 86 years of age.
  • Patients must have moderate to severe hypertension.

Patient Exclusion Criteria

  • Patients must not be on 4 or more medications for hypertension.
  • Patients must not have had a heart attack.
  • Patients must not have a history of gout.
  • Patients must not have systemic lupus erythematosus.

For more information,

Patience Chambers, Study Coordinator/Director
Dynamic Clinical Research, Inc.
1010 Carondelet Drive, Suite 130
Kansas City, MO 64114
Phone: 816-942-2626
Fax: 816-942-2634
Email: patience.chambers@sbcglobal.net

View Map

Research Center Information: Dynamic Clinical Research, Inc.

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.